MedPath
TGA Approval

PHENTERMINE SANDOZ phentermine (as hydrochloride) 40 mg sustained release capsule blister pack (379013)

379013

PHENTERMINE SANDOZ phentermine (as hydrochloride) 40 mg sustained release capsule blister pack

Aspen Pharmacare Australia Pty Ltd

March 11, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/08123d4a15027d2463417d0beb884baf.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/dbb99031a0f5f5ed58b4f8425697e3f2.pdf

Active Ingredients

phentermine hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PHENTERMINE SANDOZ phentermine (as hydrochloride) 40 mg sustained release capsule blister pack (379013) - TGA 批准文号 | MedPath